Literature DB >> 16949277

Short term psychological distress in patients actively approached for genetic counselling after diagnosis of breast cancer.

Kathryn J Schlich-Bakker1, Carla C Wárlám-Rodenhuis, Jeanne van Echtelt, Jan van den Bout, Margreet G E M Ausems, Herman F J ten Kroode.   

Abstract

This prospective study assessed anxiety, depression and breast cancer-specific distress in recently diagnosed breast cancer patients before and after an active approach for genetic counselling at the beginning of adjuvant radiotherapy (mean: 52 days after surgery). Patients completed the hospital anxiety and depression scale (HADS) and the impact of event scale (IES). Psychological distress did not increase after the approach. High anxiety decreased in the comparison group (n=182), whereas breast cancer specific distress decreased in the approached group (n=220). It is concluded that breast cancer patients can be approached for genetic counselling shortly after surgery without additional short-term psychological burden. Patients who are young, single with little social support, less optimistic, use an avoiding coping style, experience a lower quality of life or who are highly distressed prior to approach for genetic counselling, need extra attention. Medical history did not prove to be relevant.

Entities:  

Mesh:

Year:  2006        PMID: 16949277     DOI: 10.1016/j.ejca.2006.05.032

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  20 in total

Review 1.  The role of BRCA mutation testing in determining breast cancer therapy.

Authors:  Alison H Trainer; Craig R Lewis; Kathy Tucker; Bettina Meiser; Michael Friedlander; Robyn L Ward
Journal:  Nat Rev Clin Oncol       Date:  2010-11-09       Impact factor: 66.675

Review 2.  Specific psychosocial issues of individuals undergoing genetic counseling for cancer - a literature review.

Authors:  Willem Eijzenga; Daniela E E Hahn; Neil K Aaronson; Irma Kluijt; Eveline M A Bleiker
Journal:  J Genet Couns       Date:  2013-08-31       Impact factor: 2.537

3.  Are we being overly cautious? A qualitative inquiry into the experiences and perceptions of treatment-focused germline BRCA genetic testing amongst women recently diagnosed with breast cancer.

Authors:  E Zilliacus; B Meiser; M Gleeson; K Watts; K Tucker; E A Lobb; G Mitchell
Journal:  Support Care Cancer       Date:  2012-03-24       Impact factor: 3.603

4.  The impact of risk-reducing gynaecological surgery in premenopausal women at high risk of endometrial and ovarian cancer due to Lynch syndrome.

Authors:  Ramona Moldovan; Sianan Keating; Tara Clancy
Journal:  Fam Cancer       Date:  2015-03       Impact factor: 2.375

5.  When knowledge of a heritable gene mutation comes out of the blue: treatment-focused genetic testing in women newly diagnosed with breast cancer.

Authors:  B Meiser; V F Quinn; M Gleeson; J Kirk; K M Tucker; B Rahman; C Saunders; K J Watts; M Peate; E Geelhoed; K Barlow-Stewart; M Field; M Harris; Y C Antill; G Mitchell
Journal:  Eur J Hum Genet       Date:  2016-06-22       Impact factor: 4.246

6.  Psychological outcomes and surgical decisions after genetic testing in women newly diagnosed with breast cancer with and without a family history.

Authors:  Bettina Meiser; Veronica F Quinn; Gillian Mitchell; Kathy Tucker; Kaaren J Watts; Belinda Rahman; Michelle Peate; Christobel Saunders; Elizabeth Geelhoed; Margaret Gleeson; Kristine Barlow-Stewart; Michael Field; Marion Harris; Yoland C Antill; Rachel Susman; Michael T Bowen; Llew Mills; Judy Kirk
Journal:  Eur J Hum Genet       Date:  2018-03-30       Impact factor: 4.246

7.  Universal BRCA1/BRCA2 Testing for Ovarian Cancer Patients is Welcomed, but with Care: How Women and Staff Contextualize Experiences of Expanded Access.

Authors:  Hannah Shipman; Samantha Flynn; Carey F MacDonald-Smith; James Brenton; Robin Crawford; Marc Tischkowitz; Nicholas J Hulbert-Williams
Journal:  J Genet Couns       Date:  2017-05-24       Impact factor: 2.537

8.  BRCA1/2 mutation testing in breast cancer patients: a prospective study of the long-term psychological impact of approach during adjuvant radiotherapy.

Authors:  Kathryn J Schlich-Bakker; Margreet G E M Ausems; Maria Schipper; Herman F J Ten Kroode; Carla C Wárlám-Rodenhuis; Jan van den Bout
Journal:  Breast Cancer Res Treat       Date:  2007-08-03       Impact factor: 4.872

9.  Intrusion and avoidance in subjects undergoing genetic investigation and counseling for hereditary cancer.

Authors:  Cathrine Bjorvatn; Geir Egil Eide; Berit R Hanestad; Anniken Hamang; Odd E Havik
Journal:  Support Care Cancer       Date:  2009-02-18       Impact factor: 3.603

Review 10.  Genetic counselling and testing for inherited gene mutations in newly diagnosed patients with breast cancer: a review of the existing literature and a proposed research agenda.

Authors:  Bettina Meiser; Kathy Tucker; Michael Friedlander; Kristine Barlow-Stewart; Elizabeth Lobb; Christobel Saunders; Gillian Mitchell
Journal:  Breast Cancer Res       Date:  2008-11-28       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.